AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. Its product is primarily for acute allergic reaction, croup, and chemotherapy-induced nausea, and vomiting. The company was founded on November 15, 2006 and is headquartered in Lund, Sweden.